Sign Up / Log In
Account
Online Pharmacy
Doctor Services
Health Centre
Bulk Purchase
Corporate
Vildagliptin is commonly used to treat type 2 diabetes mellitus
Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor which is found to increase the incretin hormone (Glucagon-like peptide 1) and potentiate the secretion of insulin in the beta cells
Nausea, Peripheral oedema, Hypoglycaemia, Joint pain, Liver dysfunction, Upper respiratory tract infection, Skin rash, Pancreatitis
There is no known interaction between Vildagliptin and alcohol but alcohol is known to alter blood glucose level which may cause complication or uncontrolled blood sugar level in patients with diabetes mellitus.
Animal studies have shown reproductive toxicity at a high dose but there are limited data of Vitagliptin use in pregnant women. Thus, Vildagliptin is not advisable to be used during pregnancy. Please consult your doctor.
Vildagliptin has been shown to be excreted in animal milk but excretion in human milk is unknown. Thus, Vildagliptin is not advisable to be used during breastfeeding. Please consult your doctor.
There are no studies of Vildagliptin on the ability to drive. Do not drive unless you are feeling well.
Dose adjustment is required in patients with moderate to severe kidney impairment.
Vildagliptin is not advisable to be used in patients with liver impairment.